semaglutide and non alcoholic fatty liver disease Non-alcoholic disease: Immunological mechanisms current treatments The future of incretins in

People who combine GLP-1 medications with other weight management compounds should be especially careful about frequency and timing

Zepbound is FDA-approved to: Reduce excess body weight and maintain weight reduction long term in adults with obesity or who are overweight with weight-related medical problems Treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity

Switching from tirzepatide to retatrutide The safest approach based on current clinical understanding: Stop tirzepatide and allow a washout period of 1-2 weeks (tirzepatide half-life is approximately 5 days) Start retatrutide at 2 mg regardless of your previous tirzepatide dose Titrate up on the standard schedule , every 4 weeks Do not skip steps because you were on high-dose tirzepatide, the glucagon receptor is new territory for your body The rationale is straightforward

Hear their stories, see their transformations, and feel the confidence that comes from personalized, expert care

But those taking a GLP-1 for weight loss may think about reducing their dose or even stopping completely once they reach their goal weight

That warning applies regardless of whether the semaglutide is swallowed or injected, which underscores that this is one molecule with one safety profile, delivered two ways